679 related articles for article (PubMed ID: 17158282)
1. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study.
Garcia-Aymerich J; Lange P; Benet M; Schnohr P; Antó JM
Am J Respir Crit Care Med; 2007 Mar; 175(5):458-63. PubMed ID: 17158282
[TBL] [Abstract][Full Text] [Related]
2. Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study.
Watson L; Vonk JM; Löfdahl CG; Pride NB; Pauwels RA; Laitinen LA; Schouten JP; Postma DS;
Respir Med; 2006 Apr; 100(4):746-53. PubMed ID: 16199147
[TBL] [Abstract][Full Text] [Related]
3. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.
Geijer RM; Sachs AP; Verheij TJ; Salomé PL; Lammers JW; Hoes AW
Br J Gen Pract; 2006 Sep; 56(530):656-61. PubMed ID: 16953996
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.
Danielsson P; Ólafsdóttir IS; Benediktsdóttir B; Gíslason T; Janson C
Clin Respir J; 2012 Apr; 6(2):120-7. PubMed ID: 21651748
[TBL] [Abstract][Full Text] [Related]
5. Surfactant protein-B 121ins2 heterozygosity, reduced pulmonary function, and chronic obstructive pulmonary disease in smokers.
Baekvad-Hansen M; Dahl M; Tybjaerg-Hansen A; Nordestgaard BG
Am J Respir Crit Care Med; 2010 Jan; 181(1):17-20. PubMed ID: 19833825
[TBL] [Abstract][Full Text] [Related]
6. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
[TBL] [Abstract][Full Text] [Related]
7. Short telomere length, lung function and chronic obstructive pulmonary disease in 46,396 individuals.
Rode L; Bojesen SE; Weischer M; Vestbo J; Nordestgaard BG
Thorax; 2013 May; 68(5):429-35. PubMed ID: 23268483
[TBL] [Abstract][Full Text] [Related]
8. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.
Celli BR; Thomas NE; Anderson JA; Ferguson GT; Jenkins CR; Jones PW; Vestbo J; Knobil K; Yates JC; Calverley PM
Am J Respir Crit Care Med; 2008 Aug; 178(4):332-8. PubMed ID: 18511702
[TBL] [Abstract][Full Text] [Related]
9. Time-dependent confounding in the study of the effects of regular physical activity in chronic obstructive pulmonary disease: an application of the marginal structural model.
Garcia-Aymerich J; Lange P; Serra I; Schnohr P; Antó JM
Ann Epidemiol; 2008 Oct; 18(10):775-83. PubMed ID: 18708291
[TBL] [Abstract][Full Text] [Related]
10. Occupational exposure to dusts, gases, and fumes and incidence of chronic obstructive pulmonary disease in the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults.
Mehta AJ; Miedinger D; Keidel D; Bettschart R; Bircher A; Bridevaux PO; Curjuric I; Kromhout H; Rochat T; Rothe T; Russi EW; Schikowski T; Schindler C; Schwartz J; Turk A; Vermeulen R; Probst-Hensch N; Künzli N;
Am J Respir Crit Care Med; 2012 Jun; 185(12):1292-300. PubMed ID: 22492989
[TBL] [Abstract][Full Text] [Related]
11. Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?
Medbø A; Melbye H
Respir Med; 2007 Jun; 101(6):1097-105. PubMed ID: 17239575
[TBL] [Abstract][Full Text] [Related]
12. Spirometry, rapid FEV1 decline, and lung cancer among asbestos exposed heavy smokers.
Chien JW; Au DH; Barnett MJ; Goodman GE
COPD; 2007 Dec; 4(4):339-46. PubMed ID: 18027161
[TBL] [Abstract][Full Text] [Related]
13. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.
Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N
Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715
[TBL] [Abstract][Full Text] [Related]
14. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort.
Casanova C; de Torres JP; Aguirre-Jaíme A; Pinto-Plata V; Marin JM; Cordoba E; Baz R; Cote C; Celli BR
Am J Respir Crit Care Med; 2011 Nov; 184(9):1015-21. PubMed ID: 21836135
[TBL] [Abstract][Full Text] [Related]
15. Reduced lung function predicts increased fatality in future cardiac events. A population-based study.
Engström G; Hedblad B; Janzon L
J Intern Med; 2006 Dec; 260(6):560-7. PubMed ID: 17116007
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study.
Thomsen M; Nordestgaard BG; Vestbo J; Lange P
Lancet Respir Med; 2013 Sep; 1(7):543-50. PubMed ID: 24461615
[TBL] [Abstract][Full Text] [Related]
17. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study.
Prescott E; Bjerg AM; Andersen PK; Lange P; Vestbo J
Eur Respir J; 1997 Apr; 10(4):822-7. PubMed ID: 9150319
[TBL] [Abstract][Full Text] [Related]
18. Productive cough is an independent risk factor for the development of COPD in former smokers.
Yamane T; Hattori N; Kitahara Y; Haruta Y; Sasaki H; Yokoyama A; Kohno N
Respirology; 2010 Feb; 15(2):313-8. PubMed ID: 20070589
[TBL] [Abstract][Full Text] [Related]
19. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up.
Contoli M; Baraldo S; Marku B; Casolari P; Marwick JA; Turato G; Romagnoli M; Caramori G; Saetta M; Fabbri LM; Papi A
J Allergy Clin Immunol; 2010 Apr; 125(4):830-7. PubMed ID: 20227753
[TBL] [Abstract][Full Text] [Related]
20. β2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies.
Thomsen M; Nordestgaard BG; Sethi AA; Tybjærg-Hansen A; Dahl M
Eur Respir J; 2012 Mar; 39(3):558-66. PubMed ID: 22075484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
